Hyperfine shares tumble as Q4 revenue misses estimates

Published 17/03/2025, 21:32
Hyperfine shares tumble as Q4 revenue misses estimates

GUILFORD, Conn. - Hyperfine, Inc. (NASDAQ:HYPR) shares plunged 10.2% after the health technology company reported fourth quarter revenue that fell short of analyst expectations, despite meeting earnings per share estimates.

The maker of the Swoop portable MRI system posted Q4 revenue of $2.32 million, missing the consensus estimate of $3.3 million. Adjusted earnings per share came in at -$0.14, in line with analyst projections.

For the full year 2024, Hyperfine’s revenue grew 17% YoY to $12.89 million. The company sold 48 commercial Swoop systems in 2024, up from 37 in 2023.

"I am pleased with the many milestones we achieved in the fourth quarter of 2024. These set the stage well for us to execute on our expansion plan, drive accelerated growth across multiple sites of care globally and meaningfully reduce cash burn in 2025," said Maria Sainz, CEO of Hyperfine.

Looking ahead, management expects first half 2025 revenue of approximately $6 million and full year 2025 revenue growth of 20% to 30% over 2024 levels. The company also anticipates reducing its cash burn to $25-27 million in 2025, down 32% from 2024 at the midpoint.

Hyperfine ended 2024 with $37.64 million in cash and cash equivalents. The company recently raised $6 million through a registered direct offering to extend its cash runway through the end of 2026.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.